Eugenia Morello, Silvia Bosio, Sibilla Anna Teresa Salvadeo
{"title":"莫西沙星和地拉法柯治疗后的Kounis综合征。","authors":"Eugenia Morello, Silvia Bosio, Sibilla Anna Teresa Salvadeo","doi":"10.12890/2024_004971","DOIUrl":null,"url":null,"abstract":"<p><p>Kounis syndrome (KS), characterized by the simultaneous occurrence of acute coronary syndrome (ACS) and allergic reactions, can be triggered by a range of factors and drugs. We report on the case of a patient who arrived at our emergency department (ED) with symptoms of an allergic reaction after taking moxifloxacin and deflazacort orally. In the ED, the patient experienced a 5-minute episode of oppressive chest pain. A 12-lead electrocardiogram (ECG) was registered, and elevated troponin levels were detected in the blood, suggesting myocardial damage. The patient was admitted to the internal medicine department for observation, and a second 12-lead ECG demonstrated a significant variation in the repolarization pattern. The day after, a coronary angiography revealed no significant stenosis, thus supporting, along with elevated serum tryptase levels, the diagnosis of KS. This case report highlights two potential triggers for KS and emphasizes the critical importance of early recognition and prompt treatment of KS.</p><p><strong>Learning points: </strong><i>Kounis syndrome can be triggered by moxifloxacin and/or deflazacort.</i> This case report documents the onset of Kounis syndrome following the administration of moxifloxacin and deflazacort.<i>Diagnosing and treating Kounis syndrome can be challenging.</i> Its diverse triggers and clinical manifestations complicate accurate diagnosis. Effective treatment involves addressing both cardiac and allergic symptoms, with the understanding that medications used for cardiac issues may exacerbate allergic reactions, and vice versa.<i>Nonspecific electrocardiogram (ECG) alterations should not be underestimated.</i> In the context of an allergic reaction, ECG alterations, including nonspecific ones, might be an early warning sign.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":"11 12","pages":"004971"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11716304/pdf/","citationCount":"0","resultStr":"{\"title\":\"Kounis Syndrome Following Moxifloxacin and Deflazacort Administration.\",\"authors\":\"Eugenia Morello, Silvia Bosio, Sibilla Anna Teresa Salvadeo\",\"doi\":\"10.12890/2024_004971\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Kounis syndrome (KS), characterized by the simultaneous occurrence of acute coronary syndrome (ACS) and allergic reactions, can be triggered by a range of factors and drugs. We report on the case of a patient who arrived at our emergency department (ED) with symptoms of an allergic reaction after taking moxifloxacin and deflazacort orally. In the ED, the patient experienced a 5-minute episode of oppressive chest pain. A 12-lead electrocardiogram (ECG) was registered, and elevated troponin levels were detected in the blood, suggesting myocardial damage. The patient was admitted to the internal medicine department for observation, and a second 12-lead ECG demonstrated a significant variation in the repolarization pattern. The day after, a coronary angiography revealed no significant stenosis, thus supporting, along with elevated serum tryptase levels, the diagnosis of KS. This case report highlights two potential triggers for KS and emphasizes the critical importance of early recognition and prompt treatment of KS.</p><p><strong>Learning points: </strong><i>Kounis syndrome can be triggered by moxifloxacin and/or deflazacort.</i> This case report documents the onset of Kounis syndrome following the administration of moxifloxacin and deflazacort.<i>Diagnosing and treating Kounis syndrome can be challenging.</i> Its diverse triggers and clinical manifestations complicate accurate diagnosis. Effective treatment involves addressing both cardiac and allergic symptoms, with the understanding that medications used for cardiac issues may exacerbate allergic reactions, and vice versa.<i>Nonspecific electrocardiogram (ECG) alterations should not be underestimated.</i> In the context of an allergic reaction, ECG alterations, including nonspecific ones, might be an early warning sign.</p>\",\"PeriodicalId\":11908,\"journal\":{\"name\":\"European journal of case reports in internal medicine\",\"volume\":\"11 12\",\"pages\":\"004971\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11716304/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of case reports in internal medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12890/2024_004971\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2024_004971","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Kounis Syndrome Following Moxifloxacin and Deflazacort Administration.
Kounis syndrome (KS), characterized by the simultaneous occurrence of acute coronary syndrome (ACS) and allergic reactions, can be triggered by a range of factors and drugs. We report on the case of a patient who arrived at our emergency department (ED) with symptoms of an allergic reaction after taking moxifloxacin and deflazacort orally. In the ED, the patient experienced a 5-minute episode of oppressive chest pain. A 12-lead electrocardiogram (ECG) was registered, and elevated troponin levels were detected in the blood, suggesting myocardial damage. The patient was admitted to the internal medicine department for observation, and a second 12-lead ECG demonstrated a significant variation in the repolarization pattern. The day after, a coronary angiography revealed no significant stenosis, thus supporting, along with elevated serum tryptase levels, the diagnosis of KS. This case report highlights two potential triggers for KS and emphasizes the critical importance of early recognition and prompt treatment of KS.
Learning points: Kounis syndrome can be triggered by moxifloxacin and/or deflazacort. This case report documents the onset of Kounis syndrome following the administration of moxifloxacin and deflazacort.Diagnosing and treating Kounis syndrome can be challenging. Its diverse triggers and clinical manifestations complicate accurate diagnosis. Effective treatment involves addressing both cardiac and allergic symptoms, with the understanding that medications used for cardiac issues may exacerbate allergic reactions, and vice versa.Nonspecific electrocardiogram (ECG) alterations should not be underestimated. In the context of an allergic reaction, ECG alterations, including nonspecific ones, might be an early warning sign.
期刊介绍:
The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.